RGS16 (Regulator of G protein Signaling 16) activators belong to a specific chemical class that has garnered attention in the field of molecular biology and pharmacology due to their potential to modulate cellular signaling pathways mediated by G protein-coupled receptors (GPCRs). RGS proteins, including RGS16, play a crucial role in the regulation of GPCR signaling by acting as GTPase-activating proteins (GAPs) for Gα subunits of heterotrimeric G proteins. RGS16, in particular, is known for its role in attenuating GPCR signaling by accelerating the hydrolysis of GTP to GDP, effectively terminating the activation of downstream signaling cascades.
RGS16 activators are compounds or molecules that enhance the activity of RGS16, thereby augmenting its GAP function. These activators can influence GPCR-mediated signaling pathways in various cell types and tissues. By increasing the rate at which Gα subunits return to their inactive GDP-bound state, RGS16 activators help in fine-tuning the duration and intensity of GPCR signaling, allowing for more precise control over cellular responses to extracellular stimuli. Researchers are actively investigating the structural and mechanistic aspects of RGS16 activation, seeking to better understand how these compounds interact with the protein and how they can be optimized for potential research applications. Additionally, the development of RGS16 activators has the potential to shed light on the intricate regulatory mechanisms underlying GPCR signaling, offering insights into fundamental cellular processes and paving the way for future discoveries in the field of molecular biology.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates RGS16 indirectly by stimulating adenylate cyclase, leading to increased cAMP levels. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
8-Bromo-cAMP is a synthetic cAMP analog that can activate cAMP-dependent pathways, potentially involving RGS16. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol activates RGS16 indirectly by binding to beta-adrenergic receptors and triggering G-protein signaling. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
S1P activates RGS16 by binding to S1P receptors, GPCRs, with RGS16 regulating downstream signaling pathways. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $41.00 $104.00 $201.00 $1774.00 $16500.00 | ||
Epinephrine activates RGS16 indirectly by binding to adrenergic receptors, leading to G-protein activation. | ||||||
Carbachol | 51-83-2 | sc-202092 sc-202092A sc-202092C sc-202092D sc-202092B sc-202092E | 1 g 10 g 25 g 50 g 100 g 250 g | $122.00 $281.00 $388.00 $683.00 $1428.00 $3060.00 | 12 | |
Carbachol activates RGS16 indirectly via muscarinic receptors, with RGS16 potentially regulating downstream signaling. | ||||||
PGE2 | 363-24-6 | sc-201225 sc-201225C sc-201225A sc-201225B | 1 mg 5 mg 10 mg 50 mg | $57.00 $159.00 $275.00 $678.00 | 37 | |
PGE2 can activate GPCRs, with RGS16 possibly involved in terminating PGE2-mediated signaling. | ||||||
Dopamine | 51-61-6 | sc-507336 | 1 g | $290.00 | ||
Dopamine activates RGS16 indirectly via dopamine receptors, with RGS16 potentially modulating downstream signaling. | ||||||
Angiotensin II, Human | 4474-91-3 | sc-363643 sc-363643A sc-363643B sc-363643C | 1 mg 5 mg 25 mg 100 mg | $51.00 $100.00 $310.00 $690.00 | 3 | |
Angiotensin II activates RGS16 indirectly through angiotensin receptors, with RGS16 involved in regulating signaling. | ||||||
Substance P | 33507-63-0 | sc-201169 | 1 mg | $56.00 | ||
Substance P activates RGS16 indirectly via neurokinin receptors, with RGS16 playing a role in signaling termination. | ||||||